+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Mesenchymal Stem Cells Market by Type (Allogeneic, Autologous), Indication (Bone & Cartilage Repair, Cancer, Cardiovascular Disease), Source of Isolation, Application - Forecast 2023-2030- Product Image
Global Mesenchymal Stem Cells Market by Type (Allogeneic, Autologous), Indication (Bone & Cartilage Repair, Cancer, Cardiovascular Disease), Source of Isolation, Application - Forecast 2023-2030- Product Image
Sale

Global Mesenchymal Stem Cells Market by Type (Allogeneic, Autologous), Indication (Bone & Cartilage Repair, Cancer, Cardiovascular Disease), Source of Isolation, Application - Forecast 2023-2030

  • PDF Icon

    Report

  • 196 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5518254
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Mesenchymal Stem Cells Market size was estimated at USD 3.09 billion in 2022, USD 3.51 billion in 2023, and is expected to grow at a CAGR of 13.61% to reach USD 8.59 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Mesenchymal Stem Cells Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Mesenchymal Stem Cells Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Mesenchymal Stem Cells Market, highlighting leading vendors and their innovative profiles. These include Astellas Pharma Inc., Athersys, Inc., Axol Biosciences Ltd., BrainStorm Cell Therapeutics Inc., Cell Applications, Inc., Celprogen, Inc., Cyagen Biosciences, Inc., Cytori Therapeutics Inc., Genlantis, Inc., Globus Medical, Hope Biosciences, LLC, Lonza Group AG, Merck KGaA, Mesoblast Limited, Neuromics, Pluri Biotech Ltd., PromoCell GmbH, R&D Systems, Inc., ScienCell Research Laboratories, Inc., Smith & Nephew PLC, Stemcell Technologies Inc., Stemedica Cell Technologies, Inc., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific, Inc., and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Mesenchymal Stem Cells Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Allogeneic
    • Autologous
  • Indication
    • Bone & Cartilage Repair
    • Cancer
    • Cardiovascular Disease
    • GvHD
    • Inflammatory & Immunological Disease
    • Liver Diseases
  • Source of Isolation
    • Adipose Tissues
    • Bone Marrow
    • Cord Blood
    • Fallopian Tube
    • Fetal Liver
    • Lung
    • Peripheral Blood
  • Application
    • Disease Modeling
    • Drug Development & Discovery
    • Stem Cell Banking
    • Tissue Engineering
    • Toxicology Studies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Mesenchymal Stem Cells Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Mesenchymal Stem Cells Market?
  3. What are the technology trends and regulatory frameworks in the Mesenchymal Stem Cells Market?
  4. What is the market share of the leading vendors in the Mesenchymal Stem Cells Market?
  5. Which modes and strategic moves are suitable for entering the Mesenchymal Stem Cells Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Mesenchymal Stem Cells Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growth in Mesenchymal Stem Cell-Based Research
5.1.1.2. Rising Geriatric Population Coupled with Growth in Chronic Diseases
5.1.1.3. Continuously Evolving Landscape of Stem Cell Therapies
5.1.2. Restraints
5.1.2.1. Lack of Standardized and Regulated Delivery of Stem Cell Therapy
5.1.3. Opportunities
5.1.3.1. Emerging Applications of Mesenchymal Stem Cells
5.1.3.2. Growing Collaborations and Partnerships and Advancing Therapeutic Innovations of Mesenchymal Stem Cell Products
5.1.4. Challenges
5.1.4.1. Ethical & Safety Issues Associated with Human MSC Therapy
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Mesenchymal Stem Cells Market, by Type
6.1. Introduction
6.2. Allogeneic
6.3. Autologous
7. Mesenchymal Stem Cells Market, by Indication
7.1. Introduction
7.2. Bone & Cartilage Repair
7.3. Cancer
7.4. Cardiovascular Disease
7.5. GvHD
7.6. Inflammatory & Immunological Disease
7.7. Liver Diseases
8. Mesenchymal Stem Cells Market, by Source of Isolation
8.1. Introduction
8.2. Adipose Tissues
8.3. Bone Marrow
8.4. Cord Blood
8.5. Fallopian Tube
8.6. Fetal Liver
8.7. Lung
8.8. Peripheral Blood
9. Mesenchymal Stem Cells Market, by Application
9.1. Introduction
9.2. Disease Modeling
9.3. Drug Development & Discovery
9.4. Stem Cell Banking
9.5. Tissue Engineering
9.6. Toxicology Studies
10. Americas Mesenchymal Stem Cells Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Mesenchymal Stem Cells Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Mesenchymal Stem Cells Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Astellas Pharma Inc.
14.1.2. Athersys, Inc.
14.1.3. Axol Biosciences Ltd.
14.1.4. BrainStorm Cell Therapeutics Inc.
14.1.5. Cell Applications, Inc.
14.1.6. Celprogen, Inc.
14.1.7. Cyagen Biosciences, Inc.
14.1.8. Cytori Therapeutics Inc.
14.1.9. Genlantis, Inc.
14.1.10. Globus Medical
14.1.11. Hope Biosciences, LLC
14.1.12. Lonza Group AG
14.1.13. Merck KGaA
14.1.14. Mesoblast Limited
14.1.15. Neuromics
14.1.16. Pluri Biotech Ltd.
14.1.17. PromoCell GmbH
14.1.18. R&D Systems, Inc.
14.1.19. ScienCell Research Laboratories, Inc.
14.1.20. Smith & Nephew PLC
14.1.21. Stemcell Technologies Inc.
14.1.22. Stemedica Cell Technologies, Inc.
14.1.23. Takeda Pharmaceutical Company Limited
14.1.24. Thermo Fisher Scientific, Inc.
14.1.25. Vericel Corporation
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. MESENCHYMAL STEM CELLS MARKET RESEARCH PROCESS
FIGURE 2. MESENCHYMAL STEM CELLS MARKET SIZE, 2022 VS 2030
FIGURE 3. MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. MESENCHYMAL STEM CELLS MARKET DYNAMICS
FIGURE 7. MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 10. MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2022 VS 2030 (%)
FIGURE 12. MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 14. MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. MESENCHYMAL STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. MESENCHYMAL STEM CELLS MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. MESENCHYMAL STEM CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. MESENCHYMAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. MESENCHYMAL STEM CELLS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MESENCHYMAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 9. MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE & CARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. MESENCHYMAL STEM CELLS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. MESENCHYMAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. MESENCHYMAL STEM CELLS MARKET SIZE, BY GVHD, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. MESENCHYMAL STEM CELLS MARKET SIZE, BY INFLAMMATORY & IMMUNOLOGICAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. MESENCHYMAL STEM CELLS MARKET SIZE, BY LIVER DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 16. MESENCHYMAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. MESENCHYMAL STEM CELLS MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. MESENCHYMAL STEM CELLS MARKET SIZE, BY CORD BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. MESENCHYMAL STEM CELLS MARKET SIZE, BY FALLOPIAN TUBE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. MESENCHYMAL STEM CELLS MARKET SIZE, BY FETAL LIVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. MESENCHYMAL STEM CELLS MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. MESENCHYMAL STEM CELLS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. MESENCHYMAL STEM CELLS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. MESENCHYMAL STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT & DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. MESENCHYMAL STEM CELLS MARKET SIZE, BY STEM CELL BANKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. MESENCHYMAL STEM CELLS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. MESENCHYMAL STEM CELLS MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 45. CANADA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 49. MEXICO MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES MESENCHYMAL STEM CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 67. CHINA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 71. INDIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 79. JAPAN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 83. MALAYSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 87. PHILIPPINES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 91. SINGAPORE MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 95. SOUTH KOREA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 99. TAIWAN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 103. THAILAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 107. VIETNAM MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 113. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 116. DENMARK MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 120. EGYPT MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 124. FINLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 128. FRANCE MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 132. GERMANY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 136. ISRAEL MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 140. ITALY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 148. NIGERIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 151. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 152. NORWAY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 156. POLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 160. QATAR MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 175. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 176. SPAIN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 184. SWITZERLAND MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 187. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 188. TURKEY MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY SOURCE OF ISOLATION, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM MESENCHYMAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. MESENCHYMAL STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 198. MESENCHYMAL STEM CELLS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 199. MESENCHYMAL STEM CELLS MARKET LICENSE & PRICING

Companies Mentioned

  • Astellas Pharma Inc.
  • Athersys, Inc.
  • Axol Biosciences Ltd.
  • BrainStorm Cell Therapeutics Inc.
  • Cell Applications, Inc.
  • Celprogen, Inc.
  • Cyagen Biosciences, Inc.
  • Cytori Therapeutics Inc.
  • Genlantis, Inc.
  • Globus Medical
  • Hope Biosciences, LLC
  • Lonza Group AG
  • Merck KGaA
  • Mesoblast Limited
  • Neuromics
  • Pluri Biotech Ltd.
  • PromoCell GmbH
  • R&D Systems, Inc.
  • ScienCell Research Laboratories, Inc.
  • Smith & Nephew PLC
  • Stemcell Technologies Inc.
  • Stemedica Cell Technologies, Inc.
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific, Inc.
  • Vericel Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages196
PublishedMarch 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 3.51 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.59 Billion
Compound Annual Growth Rate13.6%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Mesenchymal Stem Cells Market Size, Share & Trends Analysis Report By Product & Services, By Workflow, By Type, By Source Of Isolation, By Indication, By Application, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Mesenchymal Stem Cells Market Size, Share & Trends Analysis Report By Product & Services, By Workflow, By Type, By Source Of Isolation, By Indication, By Application, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 150 Pages
  • Global
From
Mesenchymal Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Mesenchymal Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Global Mesenchymal Stem Cells Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global Mesenchymal Stem Cells Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 172 Pages
  • Global
From
Mesenchymal Stem Cells (MSC): Global Strategic Business Report - Product Image

Mesenchymal Stem Cells (MSC): Global Strategic Business Report

  • Report
  • 202 Pages
  • Global
From
Mesenchymal Stem Cell Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Mesenchymal Stem Cell Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 94 Pages
  • Global
From

About the Mesenchymal Stem Cell Market

The Mesenchymal Stem Cell (MSC) market is a rapidly growing sector of the genomics industry. MSCs are multipotent cells that can differentiate into a variety of cell types, including bone, cartilage, and fat. They are used in regenerative medicine, tissue engineering, and drug discovery. MSCs are also being studied for their potential to treat a variety of diseases, including cancer, autoimmune disorders, and cardiovascular diseases. The MSC market is driven by advances in genomics technology, such as gene editing and sequencing, which have enabled researchers to better understand the biology of MSCs and develop new therapeutic applications. Additionally, the increasing demand for personalized medicine and the growing awareness of the potential of MSCs to treat a variety of diseases are driving the growth of the MSC market. Some of the major companies in the MSC market include Thermo Fisher Scientific, Merck KGaA, Lonza Group, STEMCELL Technologies, and Cellular Dynamics International. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.